Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 87151-87200 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06378112
Extraction Socket Augmentation. A Clinical Study
PHASE4Recruiting
40 participants
Started: May 20, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT06506578
Nausea Induced by Radiation of the Dorsal Vagal Complex for Benign Brain Tumors (NausiCAA)
N/ARecruiting
100 participants
Started: May 20, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor3 locations
NCT05171868
Eye Movement Desensitization and Reprocessing (EMDR) for Police Personnel
NARecruiting
80 participants
Started: May 20, 2022 · Completed: Jun 30, 2025
3 conditions2 sponsors1 location
NCT05259553
Biomarkers in Multiple Myeloma
NARecruiting
70 participants
Started: May 20, 2022 · Completed: Oct 30, 2027
3 conditions1 sponsor2 locations
NCT06094140
NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer
PHASE2Active, not recruiting
20 participants
Started: May 20, 2022 · Completed: Jun 30, 2026
1 condition3 sponsors3 locations
NCT05328440
Treatment of Dalpiciclib Combined With Pyrotinib for Trastuzumab-sensitive HER2+ Advanced Breast Cancer(DAP-Her-02)
PHASE2Recruiting
120 participants
Started: May 20, 2022 · Completed: Jan 1, 2026
1 condition2 sponsors1 location
NCT05336864
Association of Intraoperative Blood Pressure Excursions Below Cerebral Autoregulatory Boundaries With Organ Injury Following Major Noncardiac Surgery
N/ARecruiting
650 participants
Started: May 20, 2022 · Completed: Jan 31, 2027
1 condition1 sponsor3 locations
NCT06376656
Successful Aging and Age-related Decline
NARecruiting
400 participants
Started: May 20, 2022 · Completed: May 31, 2030
5 conditions1 sponsor1 location
NCT04874441
Candida PCR Diagnosis Strategy in Patients From Intensive Care Units
NARecruiting
120 participants
Started: May 19, 2022 · Completed: Aug 1, 2025
1 condition1 sponsor1 location
NCT04981977
Enhancing the Care Transitions Intervention With Peer Support to Reduce Disparities
NAActive, not recruiting
483 participants
Started: May 19, 2022 · Completed: Jul 31, 2025
1 condition5 sponsors1 location
NCT05088395
Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4
NARecruiting
2,050 participants
Started: May 19, 2022 · Completed: Jun 1, 2031
1 condition1 sponsor2 locations
NCT05163899
Investigation of Surgical Sectioning of the Filum Terminale in Treating Occult Tethered Cord Syndrome Patients
PHASE2Recruiting
20 participants
Started: May 19, 2022 · Completed: May 31, 2028
4 conditions1 sponsor1 location
NCT05040386
Nurse Coach-Led Early Palliative Care for Older Adults With COPD and Their Care Partners: The Project EPIC Pilot RCT
NAActive, not recruiting
60 participants
Started: May 19, 2022 · Completed: Oct 1, 2025
1 condition2 sponsors1 location
NCT05393492
Regulating Emotions and Behaviors After Brain Injury
NARecruiting
77 participants
Started: May 19, 2022 · Completed: Dec 31, 2025
6 conditions1 sponsor1 location
NCT05380583
Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) and Substance Use: a Pilot Study
NARecruiting
80 participants
Started: May 19, 2022 · Completed: Jun 30, 2025
11 conditions2 sponsors1 location
NCT06794957
A Study of AL8326 in Non-Small Cell Lung Cancer
PHASE1Active, not recruiting
158 participants
Started: May 19, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor10 locations
NCT05445726
ECG Validation Study
PHASE2Active, not recruiting
141 participants
Started: May 19, 2022 · Completed: Nov 1, 2023
1 condition2 sponsors1 location
NCT05359445
IMA401 TCER® in Recurrent and/or Refractory Solid Tumors, Alone or in Combination With a Checkpoint Inhibitor
PHASE1Recruiting
95 participants
Started: May 19, 2022 · Completed: Dec 31, 2029
4 conditions1 sponsor23 locations
NCT05005208
SocIal ROBOTics for Active and Healthy Ageing
NARecruiting
20 participants
Started: May 19, 2022 · Completed: Mar 29, 2024
2 conditions2 sponsors2 locations
NCT05123703
A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis (RRMS)
PHASE3Active, not recruiting
188 participants
Started: May 19, 2022 · Completed: Sep 17, 2029
1 condition2 sponsors105 locations
NCT05576272
A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma
PHASE2/PHASE3Active, not recruiting
460 participants
Started: May 19, 2022 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05293249
dMAbs for Prevention of COVID-19
PHASE1Active, not recruiting
61 participants
Started: May 19, 2022 · Completed: Dec 31, 2025
1 condition4 sponsors1 location
NCT05817227
Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.
N/ARecruiting
300 participants
Started: May 19, 2022 · Completed: Nov 19, 2025
1 condition1 sponsor2 locations
NCT05366530
Specific Electrophenotypes in Atrial Fibrillation
N/AActive, not recruiting
300 participants
Started: May 19, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05278039
Training Swallowing Initiation During Expiration
NARecruiting
88 participants
Started: May 19, 2022 · Completed: Jul 31, 2027
4 conditions2 sponsors2 locations
NCT06883409
Laparoscopic Interval Cytoreductive Surgery in Advance Ovarian Cancer
NARecruiting
33 participants
Started: May 19, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05469022
Neoadjuvant Lazertinib Therapy in EGFR-Mutation Positive Lung Adenocarcinoma Detected by BALF Liquid Biopsy
PHASE2Recruiting
40 participants
Started: May 19, 2022 · Completed: May 19, 2027
1 condition2 sponsors1 location
NCT05018585
A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes
PHASE3Recruiting
330 participants
Started: May 19, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor60 locations
NCT05356169
Intensive Therapy Combined With Venetoclax for Adult Acute Myeloid Leukemia
PHASE2/PHASE3Active, not recruiting
312 participants
Started: May 19, 2022 · Completed: Oct 15, 2027
1 condition1 sponsor1 location
NCT05280600
Developing Advanced Neuroimaging for Clinical Evaluation of Autoimmune Encephalitis
N/ARecruiting
75 participants
Started: May 19, 2022 · Completed: Feb 28, 2026
2 conditions3 sponsors1 location
NCT05348317
Developing a Telehealth Model to Improve Treatment Access for Rural Veterans With Substance Use Disorders
NAActive, not recruiting
25 participants
Started: May 19, 2022 · Completed: Sep 30, 2026
4 conditions2 sponsors1 location
NCT04700488
Magnetic Resonance Imaging (MRI) to Predict Outcomes of Pancreatic Ductal Adenocarcinoma (PDAC)
NARecruiting
36 participants
Started: May 19, 2022 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT05055297
SELUTION4BTK Trial
NARecruiting
376 participants
Started: May 19, 2022 · Completed: Jul 30, 2032
2 conditions3 sponsors44 locations
NCT05416307
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
PHASE2/PHASE3Recruiting
156 participants
Started: May 19, 2022 · Completed: Jun 30, 2029
1 condition1 sponsor22 locations
NCT05275777
A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer
PHASE1/PHASE2Active, not recruiting
66 participants
Started: May 19, 2022 · Completed: Feb 28, 2030
2 conditions2 sponsors1 location
NCT05390827
Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol
N/ARecruiting
3,644 participants
Started: May 19, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT05293964
Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer
PHASE1Active, not recruiting
214 participants
Started: May 18, 2022 · Completed: Sep 8, 2025
1 condition2 sponsors1 location
NCT05181735
Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESA
PHASE1/PHASE2Recruiting
150 participants
Started: May 18, 2022 · Completed: Jun 19, 2029
2 conditions2 sponsors38 locations
NCT06173076
A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis
N/ARecruiting
60 participants
Started: May 18, 2022 · Completed: Dec 31, 2032
2 conditions1 sponsor1 location
NCT05208086
Diagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in Patients With Multiple Myeloma
N/ARecruiting
180 participants
Started: May 18, 2022 · Completed: May 31, 2027
1 condition1 sponsor20 locations
NCT05352685
Effects of Propofol on Auditory Event-related Potentials and Brain Functional Connectivity in Patients With Supratentorial Glioma
NARecruiting
60 participants
Started: May 18, 2022 · Completed: Sep 30, 2024
5 conditions1 sponsor1 location
NCT05277532
Effect of Circadian Rhythm and Physical Exercise in Overweight Type 1 Diabetes Patients
NARecruiting
50 participants
Started: May 18, 2022 · Completed: Oct 31, 2026
2 conditions1 sponsor1 location
NCT04987814
High-definition Surface Electromyography Markers for the Diagnosis of Sarcopenia
NARecruiting
175 participants
Started: May 18, 2022 · Completed: Dec 18, 2026
1 condition1 sponsor6 locations
NCT05396118
Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients
PHASE2Enrolling by invitation
15 participants
Started: May 18, 2022 · Completed: Dec 31, 2024
6 conditions1 sponsor1 location
NCT05383157
Brief Mindfulness Intervention for Chronic Pain in Ukraine
NARecruiting
150 participants
Started: May 18, 2022 · Completed: Dec 30, 2027
1 condition2 sponsors1 location
NCT05200481
Study of Safety and Efficacy of Brigatinib Plus Chemotherapy or Brigatinib Only in Advanced ALK-Positive Lung Cancer (MASTERPROTOCOL ALK)
PHASE2Active, not recruiting
110 participants
Started: May 18, 2022 · Completed: Oct 31, 2028
2 conditions1 sponsor29 locations
NCT05275738
The Glaucoma Nicotinamide Trial
NARecruiting
660 participants
Started: May 18, 2022 · Completed: Dec 31, 2026
1 condition10 sponsors2 locations
NCT05301283
Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue Sarcoma
PHASE2Recruiting
43 participants
Started: May 18, 2022 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT04957238
Physical Restraints in Intensive Care Unit Patients
NARecruiting
4,000 participants
Started: May 18, 2022 · Completed: Feb 27, 2026
4 conditions1 sponsor20 locations
NCT05055063
A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma
PHASE1Recruiting
30 participants
Started: May 18, 2022 · Completed: Feb 2, 2027
1 condition1 sponsor1 location